Glucose–Thymidine Ratio as a Metabolism Index Using <sup>18</sup>F-FDG and <sup>18</sup>F-FLT PET Uptake as a Potential Imaging Biomarker for Evaluating Immune Checkpoint Inhibitor Therapy

Glucose–Thymidine Ratio as a Metabolism Index Using <sup>18</sup>F-FDG and <sup>18</sup>F-FLT PET Uptake as a Potential Imaging Biomarker for Evaluating Immune Checkpoint Inhibitor Therapy

Immune checkpoint inhibitors (ICIs) are widely used in cancer immunotherapy, requiring effective methods for response monitoring. This study evaluated changes in <sup>18</sup>F-2-fluoro-2-deoxy-D-glucose (FDG) and <sup>18</sup>F-fluorothymidine (FLT) uptake by tumors followin...

Full description

Bibliographic Details
Main Authors: Sera Oh, Hyewon Youn, Jin Chul Paeng, Young-Hwa Kim, Chul-Hee Lee, Hongyoon Choi, Keon Wook Kang, June-Key Chung, Gi Jeong Cheon
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:International Journal of Molecular Sciences
Subjects:
<sup>18</sup>F-FDG
<sup>18</sup>F-FLT
metabolism index
glucose–thymidine ratio(GTR)
immune checkpoint therapy
Online Access:https://www.mdpi.com/1422-0067/23/16/9273

Internet

https://www.mdpi.com/1422-0067/23/16/9273

Similar Items